Business
Teva CFO Eyal Desheh told Merrill Lynch that it could secure antitrust clearance for the takeover in 4-7 months.
Hi, what are you looking for?
Teva CFO Eyal Desheh told Merrill Lynch that it could secure antitrust clearance for the takeover in 4-7 months.
Lawsuit is the latest in a series of bizarre events surrounding the company.
“We’re tremendously fortunate to have found such a creative, experienced and operationally strong executive."
Och-Ziff Capital Management Group plans to announce its 2014 fourth quarter and full year results, and its 2014 fourth quarter dividend, on February 5...
After it reported a 3% decline in revenue, JPMorgan is insisting its managers trim the fat from operations across the board, as reported by...
Will Howard Stern resign with Sirius/XM Satelite Radio? The company’s CFO David Frear certainly hopes so. Love him or hate him, you cannot deny...
After the controversial merger between Burger King and Canadian doughnut and coffee joint Tim Hortons was announced in August, bonuses are being dished up...
Salix Pharmaceuticals was considered as a potential buy by Allergan to ward off a hostile takeover by Valeant Pharmaceuticals and activist investor Bill Ackman....
– Former Apple Chief Financial Officer and current director of Goldman Sachs, Peter Oppenheimer, donated $20 million to Cal Poly, San...
– Amazon reported disappointing earnings yesterday, missing both revenue and profit estimates. The company’s revenue growth dropped slightly to 20% as the e-commerce giant...